Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors

Journal of Clinical Investigation

Volumn 99, Issue 5, 1997, Pages 1098-1106

  Ilan, Yaron ^a   Prakash, Renu ^a   Davidson, Anne ^a   Jona, Vinod ^a   Droguett, G ^a   Horwitz, Marshall S ^a   Chowdhury, Namita Roy ^a   Chowdhury, Jayanta Roy ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Crigler Najjar syndrome type I; gene therapy; Gunn rats; oral tolerization; recombinant adenovirus; UDP glucuronosyltransferase

Indexed keywords

GAMMA INTERFERON; GLUCURONOSYLTRANSFERASE; INTERLEUKIN 2; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; VIRUS ANTIGEN; VIRUS PROTEIN;

ADENOVIRUS 5; ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CRIGLER NAJJAR SYNDROME; CYTOTOXIC LYMPHOCYTE; GASTRODUODENOSTOMY; GENE EXPRESSION; GENE THERAPY; HISTOLOGY; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VIRUS RECOMBINANT;

EID: 0030951645     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119238     Document Type: Article

References (53)

1. Ali, M., N.R. Lemoine, and C.J.A. Ring. 1994. The use of DNA viruses as vectors for gene therapy. Gene Ther. 1:367-384.
2. Jaffe, H.A., C. Danel, and G. Longenecker. 1992. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat. Genet. 1:372-378.
3. Wilson, J.M., D.M. Jefferson, J. Roy Chowdhury, P.M. Novikoff, D.M. Johnston, and R.C. Mulligan. 1988. Retrovirus mediated transduction of adult hepatocytes. Proc. Natl. Acad. Sci. USA. 85:3014-3018.
4. Graham, F.L., and L. Prevec. 1991. Manipulation of adenovirus vectors. In Methods in Molecular Biology. E.J. Murray, editor. The Humana Press, Clifton, NJ. 109-128.
5. Takahashi, M., Y. Ilan, N. Roy Chowdhury, J. Guida, M.S. Horwitz, K. Sengupta, and J. Roy Chowdhury. 1996. Long term correction of bilirubin UDP transferase I deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal period. J. Biol. Chem. 271:26536-26542.
6. Horwitz, M.S. 1990. Adenovirudae and their replication. In Virology. B.N. Fields and D.M. Knipe, editors. Raven Press, New York. 1679-1721.
7. Prevec, L., M. Schneider, K.L. Rosenthal, L.W. Belbeck, J.B. Derbyshire, and F.L. Graham. 1989. Use of human adenovirus-hased vectors for antigen expression in animals. J. Gen. Virol. 70:429-434.
8. Yang, Y., Q. Li, H.C.J. Ertl, and J.M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 67:2004-2015.
9. Bett, A.J., L. Prevec, and F.L. Graham. 1993. Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol. 67:5911-5921.
10. Yang, Y, F.A. Nunes, K. Bercncsi, E. Gonczol, J.F. Engelhardt, and J.M. Wilson. 1994. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Genet. 7:362-369.
11. 2a in recombinant adenovirus improves transgene persistence and decreases inflammatory response in liver. Proc. Natl. Acad. Sci. USA. 91:6196-6200.
12. Weiner, H. 1994. Oral tolerance. Proc. Natl. Acad. Sci. USA. 91:10762-10765.
13. Vandenback, A.A., M. Vainiene, B. Clenik, G.A. Hashmin, A. Buenafe, and H. Offner. 1994. Definition of encephalitogenic and immunodominant epitopes of guinea pig myelin basic protein in Lewis rats tolerized neonatally with Gp-BP or Gp-BP peptides. J. Immunol. 153:852-859.
14. Hirahara, K., T. Hisatsune, K. Nishijima, H. Kato, O. Shiho, and S. Kaminogawa. 1995. CD4 T cells anergized by high dose feeding establish oral tolerance to antibody responses when transfered in SCID and nude mice. J. Immunol. 154:6238-6245.
15. Roy Chowdhury, J., N. Roy Chowdhury, C.N. Falancy, R.R. Tephly, and W. Arias. 1986. Isolation and characterization of multiple forms of rat liver UDP-glucuronide glucuronsyltransferase. Biochem. J. 233:827-837.
16. Roy Chowdhury, J., P.M. Novikoff, N. Roy Chowdhury, and A.B. Novikoff. 1985. Distribution of UDP-glucuronsyltransferase in rat tissue. Proc. Natl. Acad. Sci. USA. 82:2990-2994.
17. Crigler, J.F., and V.A. Najar. 1969. Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics. 10:169-180.
18. Bosma, P.J., N. Roy Chowdhury, B.G. Goldhorn, M.H. Hofker, R.P.J. Elferink, P.L.M. Jansen, and J. Roy Chowdhury. 1992. Sequence of exons and the flanking regions of human bilirubin UDP-glucuronsyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type 1. Hepatology. 15:941-947.
19. Ritter, J.K. J.M. Crawford, and I.S. Owens. 1991. Cloning of two human liver bilirubin-Dy UDP-Glucuronosyltransferase cDNAs with expression in COS-1 cells. J. Biol. Chem. 266:1043-1047.
20. Bosma, P.J., J. Seppen, B. Goldhoorn, C. Backer, O. Elferink, J. Roy Chowdhury, N. Roy Chowdhury, and P. Jansen. 1994. Bilirubin UDP-glucuronosyltransferase-1 is the only relevant bilirubin glucuronidating isoform in man. J. Biol. Chem. 269:17960-17964.
21. Horwitz, M.S., M.D. Scharft, and J.V. Maizel. 1969. Synthesis and assembly of Adenovirus 2: Polypeptide synthesis, assembly of capsomeres and morphogenesis of the virion. Virology. 39:682-694.
22. Mazel, J.V., D.O. White, and M.D. Scharf. 1968. The polypeptides of adenovirus: Soluble proteins, cores, top components and the structure of the virion. Virology. 36:126-136.
23. Wang, A.M., M.V. Doyle, and D.F. Mark. 1989. Quantitation of mRNA by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 86:9717-9721.
24. Peters, W.H.M., P.L.M. Allebes, L.G. Jansen, and P.J.A. Capel. 1987. Characterization and tissue specificity of a monoclonal antibody against human uridine 5′-diphosphatase-glucuronosyltransferase. Gastroenterology. 93:162-169.
25. Towbin, H., T. Staehlin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:4350-4354.
26. Trotman, B.W., J. Roy Chowdhury, and G.D. Wirt. 1982. Azodipyroles of unconjugated and conjugated bilirubin using diazotized ethyl anthranilate in dimethyl sulfoxide. Anal. Biochem. 121:175-180.
27. Roy Chowdhury, J., N. Roy Chowdhury, G. Wu, R. Shouval, and I.M. Arias. 1981. Bilirubin mono and diglucoronide formation by human liver in vitro: Assay by high pressure liquid chromatography. Hepatology. 1:622-627.
28. Seglen, P.O. 1976. Preparation of isolated rat liver cells. Methods Cell Biol. 13:29-83.
29. Taguchi, T., W.A. Archer, K. Fuijihashi, M. Yamamoto, J. McGee, J.A. Bluestone, and H. Kiguno. 1991. Novel function of intestinal intraepithelial lymphocytes. J. Immunol. 147:3736-3744.
30. Cotten, M., M. Saltik, M. Kursa, E. Wagner, G. Maas, and M.L. Birnstiel. 1994. Psoralen treatment of adenovirus particles eliminates virus replication and transcription while maintaining the endosomolytic activity of the virus capsid. Virology. 205:254-261.
31. Cotten, M., E. Wagner, K. Zaloukal, S. Phillips, D.T. Curiel, and M.L. Birnstiel. 1992. High efficiency receptor-mediated delivery of small and large gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc. Natl. Acad. Sci. USA. 89:6094-6098.
32. Dai, Y., E.M. Schwarz, D. Gu, W.W. Zhang, and N. Sarvetnick. 1995. Cellular and humoral immune responses to adenoviral vectors containing facctor IX gene: tolerization of factor IX and vector antigens allows for long term expression. Proc. Natl. Acad. Sci. USA. 92:1401-1405.
33. Yang, Y. H.C.J. Ert, and J.M. Wilson. 1994. MHC Class I restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1 deleted recombinant adenoviruses. Immunity. 1:433-442.
34. Ilan, Y., N. Roy Chowdhury, V. Jona, A. Davidson, M. Horwitz, and J. Roy Chowdhury. 1996. Transient short term FK-506 treatment permits long term gene expression using recombinant adenovirus vectors. J. Hepatol. 25:73A (Abstr.).
35. Yang, Y., G. Trinchieri, and J.M. Wilson. 1995. Recombinant IL-12 prevents formation of blocking IgA antibodies Io recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Genet. 11:211-214.
36. Ilan, Y., P. Attvar, M. Takahashi, A. Davidson, M. S. Horwitz, J. Guida, N. Roy Chowdhury, and J. Roy Chowdhury. 1996. Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats. J. Clin. Invest. 98:2640-2647.
37. Javed, N.H., I.E., Gienapp, K.L. Cox, and C.C. Whitcare. 1995. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis. J. Immunol. 155:1599-1605.
38. Khare, S.D., C.J. Krco, M.M. Griffiths, H.S. Luthra, and C.S. David. 1995. Oral administration of an immunodominant human collagen peptide modulates collagen induced arthritis. J. Immunol. 155:3653-3659.
39. Chen, Y., J.I. Inobe, and H. Weiner. 1995. Induction of oral tolerance to myelin basic protein in CD8 depleted mice: Both cells mediate active response. J. Immunol. 155:910-916.
40. Husby, S., J. Mestecky, Z. Moldoveanu, S. Holland, and C.O. Elson. 1994. Oral tolerance in humans: T cell but not B cell tolerance after antigen feeding. J. Immunol. 152:4663-4668.
41. Garside, P., M. Steel, F. Liew, and A. Mowat. 1995. CD4 but not CD8 cells are required for the induction of oral tolerance. Intern. Immunol. 7:501-504.
42. Chen, Y., J. Inobe, and H.L Weiner. 1995. Induction of oral tolerance to MBP in CD8 depleted mice. J. Immunol. 155:910-916.
43. Miller, A., O. Lider, A.B. Roberts, M. Sporn, and H. L. Weiner. 1992. Suppressor T cells generated by oral tolerance to myelin basic protein suppress both in vitro and in vivo immune responses by the release of TGFβ following antigen specific triggering. Proc. Natl. Acad. Sci. USA. 89:421-425.
44. Hancock, W., M. Polansli, J. Zhang, N. Blogg, and H. Weiner. 1995. Suppression of insulitis in NOD mice by oral insulin administration is associated with selective expression of IL-4-10, TGF-β and prostaglandine-E. Am. J. Pathol. 147:1193-1197.
45. Santos, L.M.B., A. Al-Sabbagh, A. Londono, and H.L. Weiner. 1993. Oral tolerance to myelin basic protein induces TGFβ secreting T cells in Peyer's patches. J. Immunol. 150:115A.
46. Fontana, A., D.K. Sonstan, K. Frei, U. Malipiero, and H. Pfister. 1992. Modulation of the immune response by TGFβ. Int. Arch. Allergy Immunol. 99: 1-7.
47. Weiner, H. 1995. Oral tolerance: Mobilizing the gut. Hosp. Pract. 30: 53-58.
48. Fuss, I., B. Kelsall, W. Strober, and M. Neurath. 1996. TNBS-induced experimental granulomatous colitis in mice is abrogated by the induction of TGFβ mediated oral tolerance. Gastroenterology. 110:912A.
49. Chen, Y.H., and H.L. Weiner. 1996. Dose dependent activation of antigen-specific T cells following oral tolerance. Ann. NY Acad. Sci. 778:111-121.
50. Friedman, A. 1996. Induction of anergy in TH1 lymphocytes by oral tolerance: Induction of antigen dosage and frequency of feeding. Ann. NY Acad. Sci. 778:103-110.
51. Lee, H.O., S.D. Hurst, and T.A. Barret. 1996. Antigen specific T cell responses to intragastric or intravenous antigen administration. Gastroenterology. 110:409A.
52. Poussier, P., and M. Julius. 1995. T-cell development and selection in the intestinal epithelium. Semin. Immunol. 7:321-326.
53. Fujhashi, K., S. Kahabata, T. Hiroi, and M. Yammoto. 1996. Interleukin 2 and interleukin 37 reciprocally induce IL-7 and IL-2 receptors on T-cell receptor positive intraepithelial lymphocyte. Proc. Natl. Acad. Sci. USA. 93:3613-3618.